Kidswell Bio Corporation
@kidswellbio.com
Kidswell Bio Corporation (KWB), formerly known as Gene Techno Science, has been growing by leveraging our expertise in Biosimilar field in Japan. By 2024, four BS products were brought to market by our partner pharmaceutical companies as outcomes of co-developments between the companies and KWB. Besides, KWB has engaged in research and development for regenerative medicine with stem cells from human exfoliated deciduous teeth (SHED) since 2019, which targeted pediatric diseases, orphan disease and intractable disease with the aim of achieving comprehensive healthcare solutions for patients suffering from these diseases as well as for their families and caregivers. On the 1st of April 2024, the regenerative medicine business became independent as S-Quatre Corporation (SQ). KWB and SQ lead biosimilar business and regenerative medicine business respectively, and grow together as two pillars of Kidswell Bio group. キッズウェル・バイオ株式会社(旧株式会社ジーンテクノサイエンス)はバイオシミラー医薬品事業により成長してきた。パートナー製薬企業との共同開発の結果、2024年までに4つのバイオシミラー製品を日本にて上市させている。一方で、2019年からは、乳歯由来歯髄幹細胞を用いた再生医療の研究開発に着手し、希少疾患、難病に加えて、小児疾患を重点的なターゲットと定め、患者様、及びそのご家族や介護者の方を含めた包括的なケアを目指した研究開発を行なってきた。KWBは2024年4月1日にこの再生医療事業を専門に行なう子会社である株式会社S-Quatreを設立し、現在はキッズウェル・バイオグループとしてバイオシミラーと再生医療の両事業を展開している。
Kidswell Bio Corporation's Company Logos
Kidswell Bio Corporation's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#1D2088
Jacksons Purple
29, 32, 136
238, 65, 32
79, 76, 0, 47
#EFBA6B
Porsche
239, 186, 107
36, 80, 68
0, 22, 55, 6
#00913A
Fun Green
0, 145, 58
144, 100, 28
100, 0, 60, 43
About Kidswell Bio Corporation
Kidswell Bio Corporation is a leading biopharmaceutical company that aims to be a true pharmaceutical venture. With a focus on healthcare for children, families, and society as a whole, Kidswell Bio is committed to making a positive impact on individuals and communities. The company specializes in three main areas: biopharmaceuticals, biosimilars, and cell therapy (regenerative medicine).
They have established a strong presence in these sectors through their hybrid business structure, virtual business development, and project management capabilities. Additionally, Kidswell Bio has successfully developed a platform for cell therapy, further enhancing their expertise in this field. With a robust pipeline of innovative products, Kidswell Bio is dedicated to advancing medical research and developing new treatments.
They prioritize delivering value through their biotechnology to create a better tomorrow for children around the world. Kidswell Bio is driven by their vision and the desire to contribute to the well-being of individuals and society as a whole
Company type
Public Company
Year founded
2001
Company size
11-50 employees
Related Brands
Tags
Biosimilars
Regenerative medicine
Cell therapy
Dental pulp stem cells
Biopharmaceutical development
